Aspiro Therapeutics CEO to Attend BIO CEO & Investor Conference 2025
Tucson, Arizona / January 27, 2025 — Aspiro Therapeutics, a pioneering biopharmaceutical company dedicated to developing innovative treatments for obstructive lung diseases, announced that its CEO, James Lovgren, will attend the BIO CEO & Investor Conference 2025. The conference, hosted by the Biotechnology Innovation Organization (BIO), is one of the industry’s premier events, bringing together […]